The Great Swine Flu Boondoggle
October 5, 2009 by Bob Livingston
The so-called great Swine flu pandemic is nothing more than a One World Government power grab, an effort at population control and a boondoggle designed to enrich big Pharma and its supporters.
While the United States Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and the President’s Council of Advisors on Science and Technology are predicting millions of infections and tens of thousands of deaths to come, actual figures early in the season are proving to be quite different.
Amidst all the ballyhoo, big Pharma has ramped up production of vaccines and governments are threatening to mandate—and in the case of the New York and New Jersey actually mandating—forced immunizations.
The virus, first called Swine flu and later name-changed to H1N1, first appeared in Mexico in April. Since then the WHO has declared the disease a pandemic. But as of Sept. 25, according to the WHO, there have been only 318,925 confirmed cases worldwide and only 3,917 deaths; a mortality rate of just over 1 percent. That’s a truly miniscule number. Don’t forget the seasonal flu kills an average of 3,000 people per month in the U.S. alone.
As late as August, the President’s Council of Advisors on Science predicted the H1N1 virus would infect 2 million U.S. citizens this fall and winter and result in 30,000 to 90,000 U.S. deaths.
While the flu so far is proving troublesome for those who have it and causing a higher than normal percentage of absenteeism in schools across the U.S., its effects are turning out much milder than government propagandists forecast.
This is not the first time for predictions by government scare-mongers of a worldwide Swine flu pandemic. In 1976, after one soldier at Fort Dix, N.J., collapsed during a 50 mile hike and later died, the U.S. government ramped up a Swine flu vaccine and through a massive public relations campaign, encouraged everyone in the country to be vaccinated.
This despite the fact that all known cases of Swine flu at the time were confined to 155 soldiers at Fort Dix, and none of them died.
In March of 1976, two months after the soldier’s death and with seasonal flu cases in their normal decline, the CDC asked Congress for the money to develop enough vaccine to immunize 80 percent of the U.S. population.
Four months later Congress was pushing drug companies to work faster, and drug companies asked for immunity from lawsuits if something went wrong with the vaccine. On Aug. 2, 1976, two members of the American Legion died from a respiratory disease acquired at the Legion’s convention in Philadelphia and the next day, convinced that an epidemic was beginning, Congress granted the immunity drug companies sought.
Two months later, with the government predicting at least a million deaths to come from the Swine flu, the immunization process began. By Oct. 11, 1976, approximately 40 million people had been vaccinated. Then three seniors died soon after receiving their shots.
In the ensuing days more seniors died and many otherwise healthy people began suffering debilitating neuromuscular problems and paralysis which later was diagnosed as Guillan-Barré syndrome. The Swine flu immunization was the common factor in the cases.
Drug companies that manufactured the vaccines made millions yet suffered no liability for the consequences of their untested vaccine.
It turned out in 1976 that the cure was more deadly than the disease. It looks like the same is probably going to be true this time.
The drug company GlaxoSmithKline was recently contracted by Canada to manufacture 50.4 million doses of Swine flu or H1N1 vaccine. Drug companies Baxter Pharmaceuticals and Novartis Pharmaceuticals have been commissioned to manufacture the vaccine for the U.S.
Both GlaxoSmithKline and Novartis are using the substance squalene in their H1N1 vaccines. According to The American Journal of Pathology, squalene is a cholesterol precursor which stimulates the immune system nonspecifically. One intradermal injection—or shot—of this adjuvant lipid can induce joint-specific inflammation in arthritis-prone rats.
Novartis’ squalene adjuvant was used in the experimental anthrax vaccines for soldiers serving in the Gulf War and has been linked to Gulf War Syndrome, the devastating auto-immune disease suffered by Gulf War veterans who took the anthrax shots.
Symptoms of Gulf War Syndrome include ulcers, arthritis, chronic diarrhea, fatigue and headaches, dizziness, fibromyalgia, memory loss, mood changes, multiple sclerosis, neuropsychiatric problems, rashes, skin lesions, photosensitive rashes and systemic lupus, according to osteopathic physician Joseph Mercola, M.D.
On Dr. Mercola’s website, anthrax vaccine expert Meryl Nass, M.D., wrote:
A novel feature of the two H1N1 vaccines being developed by companies Novartis and GlaxoSmithKline is the addition of squalene-containing adjuvants to boost immunogenicity and dramatically reduce the amount of viral antigen needed. This translates to much faster production of desired vaccine quantities.
Dr. Nass also writes that the squalene adjuvants have not been approved by the Food and Drug Administration (FDA) for use in any U.S. vaccine.
And then there’s Baxter.
In 2008, Baxter produced a contaminated blood thinner called heparin that had to be recalled by the FDA. It resulted in at least 81 deaths and hundreds of injuries. The active ingredient for heparin was produced in a Chinese factory that had never been inspected by the FDA.
Earlier this year it was reported that Baxter shipped what could be a weaponized version of the H591 Avian flu virus to at least 18 countries in a vaccine. The vaccine contained a live virus that had been mixed with seasonal flu viruses. The combination would have created a super-strain of virus that would have spread much more readily than normal Avian flu.
Curiously, Baxter applied for a patent for the H1N1 flu vaccine in August 2008, eight months before the H1N1 virus appeared in Mexico. This for a type of virus that had not manifested itself for more than 30 years.
In July the drug companies were given immunity from liability for the vaccines and the immunizations are about to begin with very little testing. Again, drug companies stand to make millions of dollars without fear of consequences if things go horribly wrong.
Appearing suddenly in April, the origins of the virus have either not been discovered or are known but not being revealed to the general public. Writing for the Institute of Science in Society, Professor Adrian Gibbs and Dr. Jean Downie have studied the gene sequences of the H1N1 virus and determined the virus is a combination unlike any seen in the past.
Furthermore, none of the genes that make up the virus have been seen for a long time. It appears to be a combination of Swine flu not seen in North America in more than a decade and Avian flu found in Europe but never in North America.
Gibbs and Downie posit the virus emanated either from a vaccine made specifically for pigs, accidentally from an infected human working for a drug company or intentionally released into the Mexican population.
Remembering the scare that didn’t materialize in 1976 and recognizing the hyperbole coming out of government organizations, many Americans are casting a wary eye toward the prospects of vaccination. Many of those are saying no immunization, no way.
Recognizing that their scaremongering tactics aren’t working, governments are now starting to ramp up their intimidation tactics. New York just decreed that all health workers are required to be immunized and New Jersey has mandated the same for all children in day care and preschool.
Presidential advisor and former Congressman Rham Emanuel once stated, “You should never want a serious crisis to go to waste.” Those currently in charge are doing their dead-level best not to waste this manufactured one.
If government gets away with forcing its citizens to receive a drug against their will, one more chunk will have been removed from the wall separating liberty from tyranny.